{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Poterucha TJ"],"funding":["NHLBI NIH HHS"],"pagination":["e018476"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC7955502"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["10(1)"],"pubmed_abstract":["Background Cardiovascular involvement in coronavirus disease 2019 (COVID-19) is common and leads to worsened mortality. Diagnostic cardiovascular studies may be helpful for resource appropriation and identifying patients at increased risk for death. Methods and Results We analyzed 887 patients (aged 64±17 years) admitted with COVID-19 from March 1 to April 3, 2020 in New York City with 12 lead electrocardiography within 2 days of diagnosis. Demographics, comorbidities, and laboratory testing, including high sensitivity cardiac troponin T (hs-cTnT), were abstracted. At 30 days follow-up, 556 patients (63%) were living without requiring mechanical ventilation, 123 (14%) were living and required mechanical ventilation, and 203 (23%) had expired. Electrocardiography findings included atrial fi"],"journal":["Journal of the American Heart Association"],"pubmed_title":["Admission Cardiac Diagnostic Testing with Electrocardiography and Troponin Measurement Prognosticates Increased 30-Day Mortality in COVID-19."],"pmcid":["PMC7955502"],"funding_grant_id":["R03 HL146881","T32 HL007854","K23 HL148528","R01 HL152236"],"pubmed_authors":["Griffin J","Dizon J","Kim A","Poterucha TJ","Jain SS","Redfors B","Uriel N","Gupta A","Rosenblum H","Garan H","Madhavan MV","Sayer G","Schwartz A","Clerkin KJ","Maurer MS","Morrow JP","DeFilippis EM","Yarmohammadi H","Elias P","Burkhoff D","Wan EY","Fried J","Lawlor M","Perotte A","Saluja D","Biviano AB","Rabbani L","Leon MB","Raikhelkar J","Ehlert FA"],"additional_accession":[]},"is_claimable":false,"name":"Admission Cardiac Diagnostic Testing with Electrocardiography and Troponin Measurement Prognosticates Increased 30-Day Mortality in COVID-19.","description":"Background Cardiovascular involvement in coronavirus disease 2019 (COVID-19) is common and leads to worsened mortality. Diagnostic cardiovascular studies may be helpful for resource appropriation and identifying patients at increased risk for death. Methods and Results We analyzed 887 patients (aged 64±17 years) admitted with COVID-19 from March 1 to April 3, 2020 in New York City with 12 lead electrocardiography within 2 days of diagnosis. Demographics, comorbidities, and laboratory testing, including high sensitivity cardiac troponin T (hs-cTnT), were abstracted. At 30 days follow-up, 556 patients (63%) were living without requiring mechanical ventilation, 123 (14%) were living and required mechanical ventilation, and 203 (23%) had expired. Electrocardiography findings included atrial fi","dates":{"release":"2021-01-01T00:00:00Z","publication":"2021 Jan","modification":"2025-04-22T10:49:34.791Z","creation":"2025-04-05T23:40:01.15Z"},"accession":"S-EPMC7955502","cross_references":{"pubmed":["33169643"],"doi":["10.1161/JAHA.120.018476"]}}